United States · FDA National Drug Code directory
Dapsone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69238-1627_0622cdcc-1196-4a2f-8c85-6f34f0f97f9d
- Product NDC
- 69238-1627
- Form
- GEL
- Composition / generic term
- Daspone
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230602
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPSONE — 75 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PUMP in 1 CARTON (69238-1627-6) / 60 g in 1 BOTTLE, PUMP · 69238-1627-6
- 1 BOTTLE, PUMP in 1 CARTON (69238-1627-9) / 90 g in 1 BOTTLE, PUMP · 69238-1627-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →